Literature DB >> 8565011

Ambulatory blood pressure monitoring in the diagnosis of hypertension.

L M Prisant1.   

Abstract

Noninvasive ambulatory blood pressure monitoring is a tool that may be useful for selected patients. Interest in the technology has increased because of errors and variability in clinic measurements and because of white-coat hypertension. White-coat hypertension is not benign and is associated with increased left ventricular mass and altered lipid and endocrine profiles. Ambulatory blood pressure may be useful in white-coat, borderline, and drug-resistant hypertension. Patient hook-up requires a skilled technician to adjust and calibrate the equipment and instruct the patient. Blood pressure and heart rate data should be analyzed with respect to diary entries. Observations of the diurnal curve, 24-hour, daytime, and nighttime mean blood pressure and blood pressure load are the key items in report interpretation. A 24-hour blood pressure mean of at least 134-139/84-87 mm Hg is probably indicative of hypertension. A blood pressure load of greater than 40% predicts target-organ damage. A reduced nocturnal decline is seen in many diseases but more importantly is associated with more target organ damage. The equipment used for ambulatory monitoring should be independently validated against the most recent AAMI or British Hypertension Society protocols. The performance of these devices is acceptable at rest but poor with activity. Group test-retest performance is excellent, but there is much more variability in individual patients. The variability in individuals is probably due to differences in activity and behavior. This has implications in the interpretation of ambulatory blood pressure parameters. Complications are most often related to excess repetitive inflations. Ambulatory blood pressure monitoring affects sleep mildly. Ongoing studies will define the place of ambulatory blood pressure monitoring in the care of patients.

Entities:  

Mesh:

Year:  1995        PMID: 8565011

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  5 in total

1.  Intensified monitoring of circadian blood pressure and heart rate before and after intravitreous injection of bevacizumab: preliminary findings of a pilot study.

Authors:  Focke Ziemssen; Qi Zhu; Swaantje Peters; Salvatore Grisanti; Mohammed El Wardani; Peter Szurman; Karl U Bartz-Schmidt; Tjalf Ziemssen
Journal:  Int Ophthalmol       Date:  2008-04-17       Impact factor: 2.031

2.  Ambulatory blood pressure monitoring in secondary arterial hypertension due to adrenal diseases.

Authors:  Michele Ceruti; Luigi Petramala; Dario Cotesta; Sabrina Cerci; Valentina Serra; Chiara Caliumi; Monica Iorio; Giorgio De Toma; Antonio Ciardi; Domenico Vitolo; Claudio Letizia
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-09       Impact factor: 3.738

3.  The Blood Pressure "Uncertainty Range" - a pragmatic approach to overcome current diagnostic uncertainties (II).

Authors:  Cornel Pater
Journal:  Curr Control Trials Cardiovasc Med       Date:  2005-04-06

4.  Twenty-four-hour ambulatory blood pressure monitoring in very elderly patients: Comparison of in-hospital versus home follow-up results.

Authors:  Claudia Cappelleri; Alin Janoschka; Reto Berli; Sibylle Kohler; Ruediger C Braun-Dullaeus; Ludwig T Heuss; Mathias Wolfrum
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

Review 5.  Blunted nocturnal decline in blood pressure.

Authors:  L Michael Prisant
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-10       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.